Two Top Stocks to Discuss: CECO Environmental Corp. (NASDAQ:CECE), TherapeuticsMD, Inc. (NASDAQ:TXMD)

earnings estimates

CECO Environmental Corp. (NASDAQ:CECE)

CECO Environmental Corp. (NASDAQ:CECE) closed at $7.62 on the last trading session with an increase of 0.13%, whereas, it previously closed at $7.61. The company has a market capitalization of $260.22 Million. The company traded shares of 53887 on the trading day while its three month average volume stands at 90.01 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of CECO Environmental Corp. (NASDAQ:CECE) produced diluted EPS of -0.52. The EPS estimate for next year as estimated by analysts is at 0.45 while EPS for next quarter is estimated at 0.09. Earnings per Share growth for this year is reported at 96.3, while the analysts estimated the EPS growth for next year at 0.45% and Earnings growth for next 5 years stands at 15% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -15.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of CECO Environmental Corp. (NASDAQ:CECE) is at 0 while the forward p/e is at 17.12. The P/S or Price to Sales ratio of CECO Environmental Corp. (NASDAQ:CECE) stands at 0.82 and Price to Book or P/B for the most recent quarter stands at 1.49. The Price to Free Cash Flow ratio or P/FCF is reported at 28.29. The quick ratio and the current ratio of CECO Environmental Corp. (NASDAQ:CECE) are reported at 1.1 and 1.5 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for CECO Environmental Corp. (NASDAQ:CECE) stands at -4.7, -10.5 and 1.7 respectively

The trailing twelve month Revenue of CECO Environmental Corp. (NASDAQ:CECE) is reported at 317 Million with income of -18000000. The outstanding shares of CECO Environmental Corp. (NASDAQ:CECE) are 34.15 Million. The institutional Ownership of the shares of 67.6 stands at 0.80%, this figure is increased 2.37 in the last six months. The insider ownership for the shares of CECO Environmental Corp. (NASDAQ:CECE) is ticked at 0.4%, the figure is rose 5.81% in the last six months.

Some other important financial aspects to be discussed here for CECO Environmental Corp. (NASDAQ:CECE) is the Mean Target Price estimated by the analysts which stands at 9.3. The 52 week high of CECO Environmental Corp. (NASDAQ:CECE) is placed at 9.18 and 52 week low is standing at 4.00.

Performance wise the shares of CECO Environmental Corp. (NASDAQ:CECE) rose up 4.1% for the week, it also rise 16.16% for the monthly performance, while for the quarter it went up -3.05%. The shares decrease -9.61% for the half year and flew up for the Year-To-Date performance. The shares of CECO Environmental Corp. (NASDAQ:CECE) grew 77.21% for the yearly performance.

TherapeuticsMD, Inc. (NASDAQ:TXMD)

TherapeuticsMD, Inc. (NASDAQ:TXMD) closed at $5.72 on the last trading session with an decrease of -1.89%, whereas, it previously closed at $5.83. The company has a market capitalization of $1.28 Billion. The company traded shares of 2.09 Million on the trading day while its three month average volume stands at 3.31 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of TherapeuticsMD, Inc. (NASDAQ:TXMD) produced diluted EPS of -0.52. The EPS estimate for next year as estimated by analysts is at -0.03 while EPS for next quarter is estimated at -0.17. Earnings per Share growth for this year is reported at 18.3, while the analysts estimated the EPS growth for next year at -0.03% and Earnings growth for next 5 years stands at 15% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of TherapeuticsMD, Inc. (NASDAQ:TXMD) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of TherapeuticsMD, Inc. (NASDAQ:TXMD) stands at 84.94 and Price to Book or P/B for the most recent quarter stands at 9.69. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of TherapeuticsMD, Inc. (NASDAQ:TXMD) are reported at 7.1 and 7.2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for TherapeuticsMD, Inc. (NASDAQ:TXMD) stands at -55.5, -83.5 and -59.8 respectively

The trailing twelve month Revenue of TherapeuticsMD, Inc. (NASDAQ:TXMD) is reported at 15.1 Million with income of -114700000. The outstanding shares of TherapeuticsMD, Inc. (NASDAQ:TXMD) are 224.22 Million. The institutional Ownership of the shares of 80 stands at 0.80%, this figure is increased 8.4 in the last six months. The insider ownership for the shares of TherapeuticsMD, Inc. (NASDAQ:TXMD) is ticked at 8.4%, the figure is plummeted -21.14% in the last six months.

Some other important financial aspects to be discussed here for TherapeuticsMD, Inc. (NASDAQ:TXMD) is the Mean Target Price estimated by the analysts which stands at 14.57. The 52 week high of TherapeuticsMD, Inc. (NASDAQ:TXMD) is placed at 7.66 and 52 week low is standing at 3.51.

Performance wise the shares of TherapeuticsMD, Inc. (NASDAQ:TXMD) rose up 12.38% for the week, it also rise 14.17% for the monthly performance, while for the quarter it went down 17.7%. The shares decrease -7.14% for the half year and flew up for the Year-To-Date performance. The shares of TherapeuticsMD, Inc. (NASDAQ:TXMD) grew 8.54% for the yearly performance.